Dr Cheung is a UK trained Consultant Dermatologist with a specialist interest in skin cancer and skin surgery. He is also experienced in managing a broad range of skin conditions such as acne, eczema, psoriasis, axillary (armpit) excessive sweating with botulinum toxin injections and Roaccutane for severe acne. He has also held several senior clinical leadership positions within the NHS and has been commended for his contribution to clinical research. Recently he has relocated to London where he continues to have a busy wide ranging dermatology case mix in both his NHS and non-NHS practices including treating skin cancer and skin surgery as well as removing lumps and bumps.
He graduated from Dundee Medical School in 2000 where he obtained an additional medical science degree in Pharmacology with Honours. He finished his general medical training in Birmingham. His Dermatology specialist training was undertaken in the West Midlands, which he completed in 2007 to become a Consultant Dermatologist. In 2015, he became a Fellow of the Royal College of Physicians (London) as a mark of his medical achievements.
Dr Cheung has held various medical leadership roles within the NHS, which includes the Skin Cancer Lead and clinical Cancer Lead for the Trust, and Dermatology Clinical Director. Furthermore, he has also been the regional Dermatology research lead for the West Midlands for the National Institute for Health Research (NIHR), a NHS funded body. He has also developed new clinical services such as, dermatology research, photodynamic therapy and an advanced dermatological surgery in some of the hospitals he has worked in.
Further information about his extensive clinical dermatology research experience is found in the "Additional information" section. He has also received a prestigious research award from the NIHR.
Dr Cheung has a broad range of dermatology interests enhanced by considerable experience in various medical leadership roles. He provides a holistic and realistic assessment of your skin issues.
In 2016, he was awarded the prestigious National Institute for Health Research (NIHR) Leading Commercial Principal Investigator Award. He also received earlier commendation from the same awarding Body. Furthermore, he has been the Dermatology co-lead of the NIHR West Midlands Local Clinical Research Network and was a member of the Dermatology National Specialty Group research committee. He remains part of the expert group assessing new studies.
2014 Certificate of Recognition from NIHR for excellent team leader and mentor &
consistently delivery time to target for Commercial studies
Tests to assist in the staging of cutaneous melanoma: a generic protocol. Dinnes J, Saleh D, Newton-Bishop J, Cheung S, Nathan P, Matin RN, Chuchu N, Bayliss SE, Takwoingi Y, Davenport C, Godfrey K, O'Sullivan C, Deeks JJ, Williams HC. (published 2017) Cochrane Database of Systemic Reviews 2017, issue 9
Compliance with isotretinoin national guidelines – where are we 2 years since the last audit? The results of the national isotretinoin re-audit 2014. (published 2017) L. Exton, S. T. Cheung, D. A. R. de Berker, A. Brain and M. F. Mohd Mustapa. Clin Exp Derm 2017; 381-9
British Association of Dermatologists’ national audit on nonmelanoma skin cancer excision, 2014. (pubiished 2016) D. J. Keith, D. A. R. de Berker, A. P. Bray, S. T. Cheung, A. Brain and M. F. Mohd Mustapa. Clin Exp Derm 2016; 46-53
Amenities and Features
- Wireless Internet
- Underground Station
- Family/Kids Friendly
- Accepts Credit Cards